Generation of mesenchymal stromal cells from cord blood: evaluation of in vitro quality parameters prior to clinical use.
about
Is Regenerative Medicine Ready for Prime Time in Diabetic Polyneuropathy?High-throughput immunophenotypic characterization of bone marrow- and cord blood-derived mesenchymal stromal cells reveals common and differentially expressed markers: identification of angiotensin-converting enzyme (CD143) as a marker differentiall
P2860
Generation of mesenchymal stromal cells from cord blood: evaluation of in vitro quality parameters prior to clinical use.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Generation of mesenchymal stro ...... ameters prior to clinical use.
@en
Generation of mesenchymal stro ...... ameters prior to clinical use.
@nl
type
label
Generation of mesenchymal stro ...... ameters prior to clinical use.
@en
Generation of mesenchymal stro ...... ameters prior to clinical use.
@nl
prefLabel
Generation of mesenchymal stro ...... ameters prior to clinical use.
@en
Generation of mesenchymal stro ...... ameters prior to clinical use.
@nl
P2093
P2860
P1476
Generation of mesenchymal stro ...... rameters prior to clinical use
@en
P2093
Alberta Alghisi
Anna Zilio
Chiara Lievore
Denise Peserico
Eliana Amati
Francesco Rodeghiero
Giuseppe Astori
Katia Chieregato
Manuela Rigno
Marco Ruggeri
P2860
P2888
P356
10.1186/S13287-016-0465-2
P577
2017-01-24T00:00:00Z
P6179
1074197578